PARAMETRIC PORTFOLIO ASSOCIATES LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 165 filers reported holding NEKTAR THERAPEUTICS in Q4 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2022$4,180,000
-41.6%
775,496
+46.3%
0.00%
-50.0%
Q4 2021$7,159,000
+9.9%
529,897
+46.1%
0.00%0.0%
Q3 2021$6,515,000
+44.3%
362,733
+37.8%
0.00%
+33.3%
Q2 2021$4,516,000
-18.2%
263,149
-4.7%
0.00%0.0%
Q1 2021$5,524,000
+16.0%
276,223
-1.4%
0.00%0.0%
Q4 2020$4,763,000
-23.6%
280,161
-25.5%
0.00%
-25.0%
Q3 2020$6,235,000
-30.1%
375,823
-2.4%
0.00%
-42.9%
Q2 2020$8,915,000
+28.5%
384,922
-0.9%
0.01%
+16.7%
Q1 2020$6,936,000
-23.5%
388,548
-7.5%
0.01%
-14.3%
Q4 2019$9,071,000
+6.1%
420,265
-10.5%
0.01%0.0%
Q3 2019$8,549,000
-49.5%
469,333
-1.3%
0.01%
-50.0%
Q2 2019$16,918,000
+35.5%
475,492
+28.0%
0.01%
+27.3%
Q1 2019$12,486,000
+11.9%
371,594
+9.5%
0.01%0.0%
Q4 2018$11,156,000
-44.3%
339,396
+3.3%
0.01%
-38.9%
Q3 2018$20,026,000
+47.9%
328,503
+18.5%
0.02%
+38.5%
Q2 2018$13,539,000
-63.7%
277,274
-20.9%
0.01%
-64.9%
Q1 2018$37,258,000
+44.3%
350,633
-18.9%
0.04%
+42.3%
Q4 2017$25,817,000
+184.0%
432,295
+14.1%
0.03%
+160.0%
Q3 2017$9,089,000
+44.7%
378,711
+17.9%
0.01%
+25.0%
Q2 2017$6,280,000
+7.4%
321,213
+28.9%
0.01%
-11.1%
Q1 2017$5,848,000
+106.9%
249,151
+8.2%
0.01%
+125.0%
Q4 2016$2,826,000
+6.2%
230,288
+48.6%
0.00%0.0%
Q3 2016$2,662,000
-0.6%
154,931
-17.7%
0.00%0.0%
Q2 2016$2,678,000
+4.9%
188,196
+1.3%
0.00%0.0%
Q1 2016$2,554,000
-12.6%
185,757
+7.1%
0.00%
-20.0%
Q4 2015$2,922,000
+137.0%
173,415
+54.2%
0.01%
+150.0%
Q3 2015$1,233,000
+40.0%
112,489
+59.7%
0.00%0.0%
Q2 2015$881,000
-11.3%
70,427
-21.9%
0.00%0.0%
Q1 2015$993,000
-29.6%
90,232
-0.8%
0.00%
-33.3%
Q4 2014$1,410,000
+14.2%
90,940
-11.1%
0.00%0.0%
Q3 2014$1,235,000
+10.4%
102,338
+17.3%
0.00%0.0%
Q2 2014$1,119,000
+1.6%
87,271
-3.9%
0.00%0.0%
Q1 2014$1,101,000
+2.6%
90,819
-4.0%
0.00%0.0%
Q4 2013$1,073,000
+24.6%
94,565
+14.7%
0.00%
+50.0%
Q3 2013$861,000
-7.8%
82,458
+2.0%
0.00%
-33.3%
Q2 2013$934,00080,8360.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2014
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders